Q523--Afterhours and Weekends Vascular Surgeon On Call Services. Ordering Period 1 - 09/28/2025 thru 09/27/2026

Where this opportunity stands

Every notice posted under solicitation 36C24425Q0524 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Note the winner and the end of the period of performance for the recompete.
• Follow the agency to see the next notice for this work.

Who won similar work

10 award notices on SAM.gov in the last 24 months. Matched by: Same office (244-NETWORK CONTRACT OFFICE 4 (36C244)), same product/service code (PSC) Q523.

Single-winner award sizes (10): middle half $94K to $140K, median $129K; range $5K to $281K.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Jan 22, 2026TRANSMEDICS, INC.$140KQ523--DECEASED DONOR ORGAN RECOVERY PERFUSION AND TRANSPORT VA PITTSBURGH HEALTHCARE SYSTEMMateriality: 0.02% of $TMDX revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $140K award ÷ $668.5M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Jan 15, 2026TRANSMEDICS, INC.$281KQ523--Deceased Donor Liver Recovery Perfusion and Transportation VA Pittsburgh Healthcare SystemMateriality: 0.04% of $TMDX revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $281K award ÷ $668.5M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Jan 13, 2026KEYSTONE PERFUSION SERVICES PC MOUNT PLEASANT 29466 SCG$5KQ523--Autologous Transfusion Cell Saver Services Period of Performance - POP: 03/26/2026 thru 03/25/2027No listed company matched (Materiality N/A)
• Jan 8, 2026AMERICAN NATIONAL RED CROSS, THE WASHINGTON 20006$60KQ523--Autologous Transfusion Cell Saver Service. Period of Performance: 05.01.26-04.30.27No listed company matched (Materiality N/A)
• Jan 5, 2026TRANSMEDICS, INC.$281KQ523--DECEASED DONOR ORGAN RECOVERY PERFUSION AND TRANSPORT VA PITTSBURGH HEALTHCARE SYSTEMMateriality: 0.04% of $TMDX revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $281K award ÷ $668.5M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Dec 19, 2025TRANSMEDICS, INC.$140KQ523--TransMedic Deceased Donor Liver Recovery Perfusion and Tranportation VA Pittsburgh Healthcare SystemMateriality: 0.02% of $TMDX revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $140K award ÷ $668.5M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Nov 24, 2025TRANSMEDICS, INC.$140KQ523--Emergent Deceased Organ Donor Liver Recovery, Perfusion, and Transportation VA Pittsburgh Healthcare SystemMateriality: 0.02% of $TMDX revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $140K award ÷ $668.5M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Nov 12, 2025TRANSMEDICS, INC.$96KQ523--Emergency Deceased Donor Liver Perfusion and Transportation VA Pittsburgh Healthcare SystemMateriality: 0.01% of $TMDX revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $96K award ÷ $668.5M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Sep 26, 2025TRANSMEDICS, INC.$118KQ523--EMERGENT TRANSMEDICS DCD ORGAN RECOVERY PERFUSION AND TRANSPORTATION VA PITTSBURGH HEALTHCARE SYSTEMMateriality: 0.02% of $TMDX revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $118K award ÷ $668.5M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Sep 17, 2025TRANSMEDICS, INC.$94KQ523--EMERGENCY DCD DONOR LIVER PERFUSION AND TRANSPORTATION VA PITTSBURGH HEALTHCARE SYSTEMMateriality: 0.01% of $TMDX revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $94K award ÷ $668.5M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.